JPH057365B2 - - Google Patents

Info

Publication number
JPH057365B2
JPH057365B2 JP60282979A JP28297985A JPH057365B2 JP H057365 B2 JPH057365 B2 JP H057365B2 JP 60282979 A JP60282979 A JP 60282979A JP 28297985 A JP28297985 A JP 28297985A JP H057365 B2 JPH057365 B2 JP H057365B2
Authority
JP
Japan
Prior art keywords
drug
foamed
hydrochloride
ethyl cellulose
drugs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP60282979A
Other languages
English (en)
Japanese (ja)
Other versions
JPS62145014A (ja
Inventor
Juji Makino
Hideo Matsuki
Yoshiki Suzuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Priority to JP28297985A priority Critical patent/JPS62145014A/ja
Publication of JPS62145014A publication Critical patent/JPS62145014A/ja
Publication of JPH057365B2 publication Critical patent/JPH057365B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
JP28297985A 1985-12-18 1985-12-18 活性持続型医薬品製剤 Granted JPS62145014A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP28297985A JPS62145014A (ja) 1985-12-18 1985-12-18 活性持続型医薬品製剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP28297985A JPS62145014A (ja) 1985-12-18 1985-12-18 活性持続型医薬品製剤

Publications (2)

Publication Number Publication Date
JPS62145014A JPS62145014A (ja) 1987-06-29
JPH057365B2 true JPH057365B2 (en, 2012) 1993-01-28

Family

ID=17659619

Family Applications (1)

Application Number Title Priority Date Filing Date
JP28297985A Granted JPS62145014A (ja) 1985-12-18 1985-12-18 活性持続型医薬品製剤

Country Status (1)

Country Link
JP (1) JPS62145014A (en, 2012)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0717988B1 (en) * 1993-08-20 2001-10-17 Nippon Shinyaku Company, Limited Gastric remaining preparation, swollen molding, and production process
ES2245782T3 (es) * 1993-10-13 2006-01-16 H. Joseph Horacek Formula de clonidina de liberacion prolongada.
US5484607A (en) * 1993-10-13 1996-01-16 Horacek; H. Joseph Extended release clonidine formulation
US11918689B1 (en) 2020-07-28 2024-03-05 Tris Pharma Inc Liquid clonidine extended release composition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5134879A (en) * 1974-09-19 1976-03-24 Eisai Co Ltd Bishochukuryushinoseizoho
JPS5512411A (en) * 1978-07-12 1980-01-29 Toshiba Corp Pen recorder

Also Published As

Publication number Publication date
JPS62145014A (ja) 1987-06-29

Similar Documents

Publication Publication Date Title
EP0205336B1 (en) Oral sustained release pharmaceutical preparation
ES2260253T3 (es) Composicion farmaceutica oral de liberacion controlada y absorcion prolongada.
TWI245646B (en) Press coated, pulsatile drug delivery system suitable oral administration
ES2606463T3 (es) Combinación de formas de dosificación de levodopa/carbidopa de liberación inmediata y liberación controlada
US5368861A (en) Gastric preparation with sustained release
AU774957B2 (en) Hydrodynamically balancing oral drug delivery system
KR880002673B1 (ko) 진통 캡슐제와 그 제조방법
WO2010103544A2 (en) A novel sustained release composition of compounds selected from the class of centrally acting muscle relaxants
CN108697700B (zh) 氘代多潘立酮组合物和用于治疗病症的方法
JPH0122245B2 (en, 2012)
BRPI0608853B1 (pt) composições farmacêuticas e processo para a fabricação de microgrânulos de rifaximina gastrorresistentes
KR20010074757A (ko) 장내 적소 방출형 제제
JP2012514623A (ja) １またはそれ以上のフマル酸エステルを含む医薬組成物
US20160256398A1 (en) Compositions of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine
US20100209511A1 (en) sustained release pharmaceutical formulation
JP2008540437A (ja) キニーネを含有する制御放出調合剤
JP2010524926A (ja) ウルソデオキシコール酸の高用量組成物
JP2774135B2 (ja) 固体の急速に崩壊する剤形
JPH09508381A (ja) 放出調節型メトロニダゾール組成物およびその製造方法と使用方法
JPH057365B2 (en, 2012)
CN115721600B (zh) 一种胃滞留型普瑞巴林缓释组合物及其制备方法
JPH057367B2 (en, 2012)
ES2317450T3 (es) Formulacion de liberacion controlada de acido valproico y sus derivados.
US7198803B2 (en) Sustained release oral preparations
JPH0448773B2 (en, 2012)

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term